Study of a Nutritional Supplement With Resveratrol, Quercetin, Taurine, Inulin, and Whey Protein to Improve Liver Health in Adults With Chronic Hepatitis C
Led by University of Guadalajara · Updated on 2026-03-23
26
Participants Needed
2
Research Sites
6 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein can improve biochemical, molecular, and clinical markers in patients with liver disease caused by chronic hepatitis C infection. The trial compares this supplement to whey protein alone to see if the combination offers extra benefits for liver-related health and clinical outcomes.
Participants will take either the investigational supplement or the active control whey protein alone daily for 12 weeks. They will attend clinic visits every 4 weeks during this period for laboratory tests and clinical evaluations to monitor progress and effects.
During the study, participants will undergo assessments including liver function tests, quality of life questionnaires CLDQ, and frailty evaluations using grip strength, timed chair stands, and balance tests. Researchers will also measure pro-inflammatory cytokines and antioxidant activity. The study aims to collect these data from enrollment through the 12-week treatment period to evaluate the supplements impact.
CONDITIONS
Brief Title
Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).
Research Team
J
Juan Roberto Rodriguez-Echevarria, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Patients with liver disease secondary to chronic hepatitis C virus infection attending the outpatient Hepatitis Clinic
Child-Pugh score less than 8 points
Age between 18 and 69 years
Both sexes eligible
Signed informed consent
You will not qualify if you...
Alcohol consumption within the past 6 months
History of acute-on-chronic liver failure (ACLF)
Persistent hepatic encephalopathy
Unable to perform frailty assessments
Refractory ascites
History of hepatorenal syndrome
History of hepatopulmonary syndrome
Chronic kidney disease
Autoimmune diseases
Any type of cancer
Dementia or significant mental illnesses
Use of protein supplements or probiotics
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - 12 weeks
Participants receive a powdered nutritional supplement containing resveratrol, quercetin, taurine, whey protein, and inulin or whey protein alone to assess hepatoprotective effects.
Visits at enrollment and periodic follow-ups during the 12-week treatment period
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Study of a Nutritional Supplement With Resveratrol, Quercetin, Taurine, Inulin, and Whey Protein to Improve Liver Health in Adults With Chronic Hepatitis C
Evaluation of Hepatology Home Hospital Care for Adults With Advanced Liver Disease in a Pilot Program
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
An Observational Study of Clinical Processes, Barriers, and Implementation Strategies
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.